Search Results
Results for: ALL (Save this search)
Number of Results: 1000
NEURELIS ACQUIRES DRUG DELIVERY TECH COMPANY AEGIS THERAPEUTICS
California, US-based pharmaceutical company Neurelis, Inc. has acquired San Diego, US-based drug delivery technology company Aegis Therapeutics, the company said.Neurelis said the ...

LIBERTY HALL CAPITAL PARTNERS ACQUIRES AIRCRAFT PERFORMANCE GROUP
South Carolina, US-based aerospace and defense industry-focussed private equity firm Liberty Hall Capital has acquired Colorado, US-based Aircraft Performance Group, Inc. (APG), a ...

Takeda Executes Loan Agreement in Connection with Shire Acquisition
4 December 2018 - Japanese drugmaker Takeda Pharmaceutical Company Ltd. (TSX: 4502) has entered into a loan agreement with the Japan Bank for International Cooperation for an aggre...

Sangamo Closes Full Acquisition of French Immunotherapies Developer TxCell
4 December 2018 - US-based genomic therapies developer Sangamo Therapeutics, Inc. (NASDAQ: SGMO) has closed the acquisition of French immunotherapies developer TxCell S.A. (PAR: TX...

MJardin Group Closes Acquisition of GrowForce to Strengthen Global Cannabis Management Platform
4 December 2018 - Denver, US-based cannabis management company MJardin Group, Inc. (CSE: MJAR) has closed the acquisition of 100% of the outstanding shares of Canada-based integrat...

PPG Closes Acquisition of Automotive Refinish Products Manufacturer SEM Products
4 December 2018 - US-based coatings company PPG (NYSE: PPG) has closed the acquisition of US-based specialised automotive refinish products manufacturer SEM Products, Inc., the com...

BayCom Closes USD 23.5m Acquisition of Bethlehem Financial
4 December 2018 - California, US-based BayCom Corp, (NASDAQ: BCML) the holding company for United Business Bank and Bethlehem Financial Corp. (BFC), has closed the acquisition of 1...

TAKEDA EXECUTES LOAN AGREEMENT IN CONNECTION WITH SHIRE ACQUISITION
Japanese drugmaker Takeda Pharmaceutical Company Ltd. (TSX: 4502) has entered into a loan agreement with the Japan Bank for International Cooperation for an aggregate principal amo...

SANGAMO CLOSES FULL ACQUISITION OF FRENCH IMMUNOTHERAPIES DEVELOPER TXCELL
US-based genomic therapies developer Sangamo Therapeutics, Inc. (NASDAQ: SGMO) has closed the acquisition of French immunotherapies developer TxCell S.A. (PAR: TXCL), the company s...

You can compare news articles by clicking on the tick buttons
<  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56   57   58   59   60   61   62   63   64   65   66   67   68   69   70   71   72   73   74   75   76   77   78   79   80   81   82   83   84   85   86   87   88   89   90   91   92   93   94   95   96   97   98   99   100   >